SELA President Dr. Harold E. Bays Awarded the NLA’s 2015 President’s Service Award

Last Updated: Thursday, 23-Jul-2015 04:00:00 EDT
Dr. Harold E. Bays, Louisville resident and SELA President, was recently awarded the President’s Service Award at the National Lipid Association’s 2015 Annual Sessions. This award recognizes an individual for service and dedication to the NLA, and advancing the development of the specialty of clinical lipidology. It is presented at the discretion of the NLA president, and multiple awards may be presented annually.
 
Dr. Harold Bays is board certified in endocrinology and internal medicine, and has participated as an investigator for more than 400 Phase I-IV clinical trials regarding treatments for dyslipidemias, obesity, diabetes mellitus, hypertension and other metabolic and hormonal disorders. He is also a Diplomate of the American Board of Clinical Lipidology. As medical director and president of Louisville Metabolic and Atherosclerosis Research Center, Dr. Bays has written or served as a contributing author to approximately 200 published scientific manuscripts and book chapters, as well as over 100 scientific abstracts presented at major scientific meetings. 
 
Dr. Bays is a fellow of the National Lipid Association (FNLA), fellow of the Obesity Society (FTOS) and fellow of the American Association of Clinical Endocrinologists (FACE). He has served as an adviser/consultant to numerous pharmaceutical companies with regard to drug development, protocol writing, statistical analyses, regulatory application, FDA Advisory panel presentations and patent assistance. Dr. Bays originated the term “adiposopathy” (“sick fat”), which defines how and when the pathologic consequences of adipose tissue accumulation promotes metabolic disease, including dyslipidemia, diabetes mellitus and hypertension. 
 
Dr. Bays is a co-author of the NLA Annual Summary of Clinical Lipidology 2015, of the American Society of Bariatric Physician Obesity Algorithm, and was chairman of the National Lipid Association 2012 Adiposity and Dyslipidemia Consensus Conference and chairman of the 2010 American Association of Clinical Endocrinologist Adipose Tissue Pathophysiology State of the Science Conference.